Published in Br J Pharmacol on June 01, 1993
Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists. Br J Pharmacol (2002) 0.87
Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor. Br J Pharmacol (1993) 0.80
Poster communications. Br J Pharmacol (1993) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci (1990) 4.34
Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem (1984) 3.39
Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci (1988) 3.13
How does adenosine inhibit transmitter release? Trends Pharmacol Sci (1988) 2.20
Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci (1990) 1.84
Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res (1981) 1.80
Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience (1980) 1.56
Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res (1974) 1.56
Actions of several anthelmintics and insecticides on rat cortical neurones. Brain Res (1970) 1.41
Pertussis toxin reverses adenosine inhibition of neuronal glutamate release. Nature (1985) 1.40
Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem (1988) 1.28
Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract. Brain Res (1978) 1.25
The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience (1991) 1.24
Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine. J Neurosci (1982) 1.19
Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding. Biochem Pharmacol (1992) 1.17
Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability. Brain Res Bull (1992) 1.16
Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature (1982) 1.15
Mild hypothermia prevents ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab (1990) 1.11
Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke (1990) 1.05
In vivo binding to peripheral benzodiazepine binding sites in lesioned rat brain: comparison between [3H]PK11195 and [18F]PK14105 as markers for neuronal damage. J Neurochem (1990) 0.98
Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res (1987) 0.98
Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res (1988) 0.97
Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist. Epilepsy Res (1989) 0.96
Protective effect of cyclohexyl adenosine in treatment of cerebral ischemia in gerbils. Neuroscience (1989) 0.93
Inhibition of [3H] glutamate release from rat hippocampal slices by L-phenylisopropyladenosine. Acta Physiol Scand (1985) 0.93
A1 and A2 adenosine receptors modulate acetylcholine release from brain slices. Eur J Pharmacol (1984) 0.92
Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. J Neurochem (1992) 0.92
Postischemic hypothermia fails to reduce ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab (1991) 0.92
Effect of theophylline on ischemically induced hippocampal damage in Mongolian gerbils: a behavioral and histopathological study. J Cereb Blood Flow Metab (1987) 0.91
Critical levels of extracellular glutamate mediating gerbil hippocampal delayed neuronal death during hypothermia: brain microdialysis study. Neuroscience (1991) 0.88
The effect of kainic, quinolinic and beta-kainic acids on the release of endogenous amino acids from rat brain slices. Biochem Pharmacol (1986) 0.87
Kainic acid: insights into excitatory mechanisms causing selective neuronal degeneration. Ciba Found Symp (1987) 0.87
A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effects on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat. Br J Pharmacol (1991) 0.86
[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia. Brain Res (1982) 0.85
Kynurenate inhibition of cell excitation decreases stroke size and deficits. Ann Neurol (1987) 0.84
Only certain anticonvulsants protect against kainate neurotoxicity. Neurobehav Toxicol Teratol (1981) 0.83
Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5-4864 in trout and mouse brain membranes. J Neurochem (1989) 0.83
Systemic injection of kainic acid: gliosis in olfactory and limbic brain regions quantified with [3H]PK 11195 binding autoradiography. Exp Neurol (1990) 0.83
MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats. Neuroscience (1990) 0.83
Release of Ca2+ from heart and kidney mitochondria by peripheral-type benzodiazepine receptor ligands. Int J Biochem (1991) 0.83
5-Aminoimidazole-4-carboxamide riboside (AICAr) administration reduces cerebral ischemic damage in the Mongolian gerbil. Brain Res Bull (1990) 0.82
Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension. Neurosci Lett (1989) 0.81
2-chloroadenosine attenuates kainic acid-induced toxicity within the rat straitum: relationship to release of glutamate and Ca2+ influx. Br J Pharmacol (1989) 0.81
Kainic acid evoked release of D-[3H]aspartate from rat striatum in vitro: characterization and pharmacological modulation. Can J Physiol Pharmacol (1984) 0.81
Kainic acid neurotoxicity; effect of systemic injection on neurotransmitter markers in different brain regions. Brain Res (1981) 0.80
The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia. Eur J Pharmacol (1990) 0.80
In vivo microdialysis studies on the effects of decortication and excitotoxic lesions on kainic acid-induced calcium fluxes, and endogenous amino acid release, in the rat striatum. J Neurochem (1987) 0.80
Increase in omega 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide. Brain Res (1991) 0.79
2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicity. Neurosci Lett (1991) 0.78
Alterations in benzodiazepine and GABA receptor binding in rat brain following systemic injection of kainic acid. Neuropharmacology (1983) 0.77
Adenosine analogues. The temperature-dependence of the anticonvulsant effect and inhibition of 3H-D-aspartate release. Biochem Pharmacol (1986) 0.76
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 2.99
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol (1981) 2.02
Physiological roles for adenosine and adenosine 5'-triphosphate in the nervous system. Neuroscience (1981) 1.85
Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus. Nature (1981) 1.50
Increased kynurenic acid levels in Huntington's disease. Lancet (1988) 1.43
Quinolinic acid and other kynurenines in the central nervous system. Neuroscience (1985) 1.34
Efflux characteristics of isotopically labelled gamma-aminobutyric acid (GABA) and L-glutamate in the rat cuneate nucleus [proceedings]. Br J Pharmacol (1977) 1.32
Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem (2005) 1.31
The release of endothelium-derived relaxant factor is calcium dependent. Blood Vessels (1985) 1.23
Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system. J Pharmacol Exp Ther (1983) 1.19
Cortical pyramidal tract interneurones and their sensitivity to L-glutamic acid. J Physiol (1973) 1.18
Antagonism by clonidine of neuronal depressant responses to adenosine, adenosine-5'-monophosphate and adenosine triphosphate. Br J Pharmacol (1978) 1.17
Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr (2001) 1.13
Microiontophoretic studies of the effects of cylic nucleotides on excitability of neurones in the rat cerebral cortex. J Physiol (1977) 1.09
Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol (2006) 1.08
Actions of adenine dinucleotides on the vas deferens, guinea-pig taenia caeci and bladder. Eur J Pharmacol (1981) 1.08
Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol (1999) 1.08
The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol (1990) 1.07
Cholinergic mechanisms in the rat somatosensory cerebral cortex. J Physiol (1972) 1.07
Adenosine inhibition of gamma-aminobutyric acid release from slices of rat cerebral cortex. Br J Pharmacol (1980) 1.07
Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci (2007) 1.05
Glutamate as the neurotransmitter of cerebellar granule cells in the rat: electrophysiological evidence. Br J Pharmacol (1979) 1.03
Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine. Br J Pharmacol (1976) 1.02
Quinolinic acid: regional variations in neuronal sensitivity. Brain Res (1983) 1.02
Phosphonate analogues of carboxylic acids as aminoacid antagonists on rat cortical neurones. Neurosci Lett (1981) 1.02
Amino acid pharmacology in neocortical slices: evidence for bimolecular actions from an extension of the Hill and Gaddum-Schild equations. Br J Pharmacol (1988) 1.02
A DNA analysis program designed for computer novices working in an industrial-research environment. Nucleic Acids Res (1984) 1.01
Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists. Neuroscience (1998) 1.00
Blockade by amino acid antagonists of neuronal excitation mediated by the pyramidal tract. J Physiol (1976) 1.00
Cortical responses to pyramidal tract stimulation in the rat. Exp Neurol (1972) 1.00
Purine receptors in the rat anococcygeus muscle. J Physiol (1983) 1.00
Action of purine and pyrimidine nucleotides on the rat superior cervical ganglion. Br J Pharmacol (1993) 1.00
Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus. Brain Res (1996) 0.98
Adenine dinucleotide effects on rat cortical neurones. Brain Res (1981) 0.98
Are noradrenaline excitations artefacts? Nature (1971) 0.97
Amino acids as neurotransmitters of corticofugal neurones in the rat: a comparison of glutamate and aspartate. Br J Pharmacol (1979) 0.97
Tryptophan loading induces oxidative stress. Free Radic Res (2004) 0.96
Comparison of the effects of ethylenediamine analogues and gamma-aminobutyric acid on cortical and pallidal neurones. Br J Pharmacol (1982) 0.96
Blockade of striatal neurone responses to morphine by aminophylline: evidence for adenosine mediation of opiate action. Br J Pharmacol (1980) 0.95
Activation of Rho GTPases by synaptic transmission in the hippocampus. J Neurochem (2003) 0.94
Neuronal responses to ethylenediamine: preferential blockade by bicuculline. Neurosci Lett (1981) 0.93
Ethylenediamine as a specific releasing agent of gamma-aminobutyric acid in rat striatal slices. J Neurochem (1982) 0.93
Neuronal responses to extracellularly applied cyclic AMP:Role of the adenosine receptor. Experientia (1978) 0.93
Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro. Eur J Pharmacol (1998) 0.93
A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro. Br J Pharmacol (1988) 0.92
The effect of theophylline on essential tremor: the possible role of GABA. Pharmacol Biochem Behav (1991) 0.91
Effect of changing extracellular levels of magnesium on spontaneous activity and glutamate release in the mouse neocortical slice. Br J Pharmacol (1989) 0.90
Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol (1995) 0.90
The activity of phosphorothioate analogues of ATP in various smooth muscle systems. Br J Pharmacol (1985) 0.90
The role of kynurenines in diabetes mellitus. Med Hypotheses (1985) 0.90
Isomers of 2-amino-7-phosphonoheptanoic acid as antagonists of neuronal excitants. Neurosci Lett (1982) 0.90
Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology (Berl) (1996) 0.89
Long-term potentiation protects rat hippocampal slices from the effects of acute hypoxia. Brain Res (2001) 0.89
Cyclic AMP and cyclic GMP may mediate opposite neuronal responses in the rat cerebral cortex. Science (1975) 0.89
Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res (1998) 0.89
An electrophysiological demonstration of a synergistic interaction between norepinephrine and adenosine in the cerebral cortex. Brain Res (1978) 0.88
The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid. Br J Pharmacol (1981) 0.88
Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo. Br J Pharmacol (1988) 0.88
Inhibition by purines of the inotropic action of isoprenaline in rat atria. Br J Pharmacol (1983) 0.88
Distribution of Rho family GTPases in the adult rat hippocampus and cerebellum. Brain Res Mol Brain Res (2003) 0.88
The effect of kainic, quinolinic and beta-kainic acids on the release of endogenous amino acids from rat brain slices. Biochem Pharmacol (1986) 0.87
Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists. Br J Pharmacol (2002) 0.87
Neurotoxicity of tryptophan metabolites. Biochem Soc Trans (2007) 0.87
Effects of topically applied excitatory amino acids on evoked potentials and single cell activity in rat cerebral cortex. Eur J Pharmacol (1986) 0.87
Nitric oxide synthase inhibitors L-NAME and 7-nitroindazole protect rat hippocampus against kainate-induced excitotoxicity. Neurosci Lett (1998) 0.86
Coenzyme A or adenosine inhibiting acetylcholine release? Nature (1978) 0.86
Increased long-term potentiation in the CA1 region of rat hippocampus via modulation of GTPase signalling or inhibition of Rho kinase. Neuropharmacology (2004) 0.86
The mouse neocortical slice: preparation and responses to excitatory amino acids. Comp Biochem Physiol C (1987) 0.86
Characterization of the adenosine receptors of the rat superior cervical ganglion. Br J Pharmacol (1993) 0.86
A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effects on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat. Br J Pharmacol (1991) 0.86
Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci (1997) 0.86
Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation. J Neurol Sci (1999) 0.86
Uptake and calcium-dependent release of ethylenediamine (1,2-diaminoethane) by rat brain slices. J Neurochem (1982) 0.86
Presynaptic actions of adenosine are magnesium-dependent. Neuropharmacology (1988) 0.85
4-Aminopyridine blockade of neuronal depressant responses to adenosine triphosphate. Br J Pharmacol (1980) 0.85
Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis. Clin Exp Rheumatol (2005) 0.85
Is adenosine the mediator of opiate action on neuronal firing rate? Nature (1979) 0.85
On the mechanism of action of clonidine: effects on single central neurones. Br J Pharmacol (1974) 0.85
The effects of cyclic dicarboxylic acids on spontaneous and amino acid-evoked activity of rat cortical neurones. Br J Pharmacol (1982) 0.85
Characteristics of the release of adenosine from slices of rat cerebral cortex. J Physiol (1980) 0.84
Increased expression of dendritic mRNA following the induction of long-term potentiation. Brain Res Mol Brain Res (1998) 0.84
Activation of thermogenesis of brown fat in rats by baclofen. Neuropharmacology (1986) 0.84
Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease. Brain Res Bull (2004) 0.84
Cell-membrane receptors for purines. Review. Biosci Rep (1982) 0.84
Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury. J Neurochem (2006) 0.84
Differential blockade of ATP, noradrenaline and electrically evoked contractions of the rat vas deferens by nifedipine. Eur J Pharmacol (1981) 0.83
Interaction between adenosine and GABAA receptors on hippocampal neurones. Brain Res (1994) 0.83
A comparison of the anticonvulsant potency of (+/-) 2-amino-5-phosphonopentanoic acid and (+/-) 2-amino-7-phosphonoheptanoic acid. Neuroscience (1983) 0.83
Therapeutic and "dose-dependent" effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease. J Neurosci Res (1999) 0.83
Interactions of adenosine and magnesium on rat hippocampal slices. Brain Res (1988) 0.83
Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo. Br J Pharmacol (1992) 0.82
Noradrenaline effects and pH. J Pharm Pharmacol (1972) 0.82
Ethylenediamine and GABA potentiation of [3H]diazepam binding to benzodiazepine receptors in rat cerebral cortex. J Neurochem (1982) 0.82
Clonidine as an adenosine antagonist. J Pharm Pharmacol (1978) 0.82
Possible roles for purine compounds in neuronal adaptation. Biochem Soc Trans (1978) 0.82
Changes in adenosine sensitivity in the hippocampus of rats with streptozotocin-induced diabetes. Br J Pharmacol (1992) 0.82
Pharmacological receptors and the control of cell function. Arch Int Pharmacodyn Ther (1974) 0.82
Characterisation of ATP-induced facilitation of transmission in rat hippocampus. Eur J Pharmacol (2000) 0.82
Activation of NMDA receptor-coupled channels suppresses the inhibitory action of adenosine on hippocampal slices. Brain Res (1990) 0.82
Effects of anticonvulsants on responses to excitatory amino acids applied topically to rat cerebral cortex. Gen Pharmacol (1988) 0.82